Literature DB >> 26415986

Effect of co-administration of probiotics with polysaccharide based colon targeted delivery systems to optimize site specific drug release.

G Prudhviraj1, Yogyata Vaidya1, Sachin Kumar Singh1, Ankit Kumar Yadav1, Puneet Kaur1, Monica Gulati2, K Gowthamarajan3.   

Abstract

Significant clinical success of colon targeted dosage forms has been limited by their inappropriate release profile at the target site. Their failure to release the drug completely in the colon may be attributed to changes in the colonic milieu because of pathological state, drug effect and psychological stress accompanying the diseased state or, a combination of these. Alteration in normal colonic pH and bacterial picture leads to incomplete release of drug from the designed delivery system. We report the effectiveness of a targeted delivery system wherein the constant replenishment of the colonic microbiota is achieved by concomitant administration of probiotics along with the polysaccharide based drug delivery system. Guar gum coated spheroids of sulfasalazine were prepared. In the dissolution studies, these spheroids showed markedly higher release in the simulated colonic fluid. In vivo experiments conducted in rats clearly demonstrated the therapeutic advantage of co-administration of probiotics with guar gum coated spheroids. Our results suggest that concomitant use of probiotics along with the polysaccharide based delivery systems can be a simple strategy to achieve satisfactory colon targeting of drugs.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Colon targeted delivery system; Dissolution; Probiotics; Spheroids; Sulfasalazine; Ulcerative colitis

Mesh:

Substances:

Year:  2015        PMID: 26415986     DOI: 10.1016/j.ejpb.2015.09.012

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  4 in total

Review 1.  Drug-gut microbiota interactions: implications for neuropharmacology.

Authors:  Jacinta Walsh; Brendan T Griffin; Gerard Clarke; Niall P Hyland
Journal:  Br J Pharmacol       Date:  2018-06-28       Impact factor: 8.739

2.  Novel biorelevant dissolution medium as a prognostic tool for polysaccharide-based colon-targeted drug delivery system.

Authors:  Ankit Kumar Yadav; Manik Sadora; Sachin Kumar Singh; Monica Gulati; Peddi Maharshi; Abhinav Sharma; Bimlesh Kumar; Harish Rathee; Deepak Ghai; Adil Hussain Malik; Varun Garg; K Gowthamrajan
Journal:  J Adv Pharm Technol Res       Date:  2017 Oct-Dec

3.  Gut microbiota-driven drug metabolism in inflammatory bowel disease.

Authors:  Femke Crouwel; Hans J C Buiter; Nanne K de Boer
Journal:  J Crohns Colitis       Date:  2020-07-11       Impact factor: 9.071

Review 4.  The Impact of the Gut Microbiota on Drug Metabolism and Clinical Outcome.

Authors:  Elaine F Enright; Cormac G M Gahan; Susan A Joyce; Brendan T Griffin
Journal:  Yale J Biol Med       Date:  2016-09-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.